未登录

P

Pablo Cabral

Universidad de la Republica

H指数:18

被引数:950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Modular Antibody-Based Platform for PD-L1 Pretargeted SPECT Imaging and In Vitro 177Lu Cytotoxicity in a Murine Melanoma Model

基于抗体的模块化平台用于PD-L1预靶向SPECT成像及在小鼠黑色素瘤模型中的177Lu细胞毒性研究

IF4.6

2026-11-130

OAAI

Molecular recognition of halogen-bond of Diiodine with an Ambidentate ligand: Fluorometry as lead strategy for analysis in solution

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-02-010

PRE

Using 137Cs and 210Pbex to assess soil redistribution at different temporal scales along with lithogenic radionuclides to evaluate contrasted watersheds in the Uruguayan Pampa grassland

IF6.6

2023-07-018

OAAI

T908 Polymeric Micelles Improved the Uptake of Sgc8-c Aptamer Probe in Tumor-Bearing Mice: A Co-Association Study between the Probe and Preformed Nanostructures

PHARMACEUTICALS

IF4.8

2021-12-238

OAAI

99mTc Stearyl 6-(benzylidenehydrazinyl) nicotinamide Liposomes as Tumor Permeability Evaluation Tracer

AAPS PHARMSCITECH

IF4

2021-03-241

PRE

Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of Cancer

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2020-10-0638

PREAI

Glucosylated Polymeric Micelles Actively Target a Breast Cancer Model

葡萄糖基化聚合物胶束积极靶向乳腺癌模型

ADVANCED THERAPEUTICS

IF2.6

2020-05-1310

PREAI

Carboranylanilinoquinazoline EGFR-inhibitors: toward 'lead-to-candidate' stage in the drug-development pipeline

FUTURE MEDICINAL CHEMISTRY

IF3.4

2019-10-0418

OAAI

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D-Aromatic-Boron-Rich-Cluster into the 4-Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2017-12-2256

PREAI

Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2017-11-2411

PREAI

Small-Molecule Kinase-Inhibitors-Loaded Boron Cluster as Hybrid Agents for Glioma-Cell-Targeting Therapy

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2017-07-0350

PREAI

Development of new PTK7-targeting aptamer-fluorescent and - radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2017-02-0134

PREAI

99mTc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-03-0146

OAAI

Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain

IF7.3

2015-07-2020

OAAI

Aptamer-HYNIC-99mTc: A molecular imaging agent of PTK7

NUCLEAR MEDICINE AND BIOLOGY

IF3

2014-08-013

PREAI

Labelling PAMAM dendrimers with Tc-99m via HYNIC

NUCLEAR MEDICINE AND BIOLOGY

IF3

2014-08-010

PREAI

Biological evaluation of two glucose derivatives radiolabeled with 99mTc as potential cancer imaging agents

NUCLEAR MEDICINE AND BIOLOGY

IF3

2014-08-010

PREAI

Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model

NUCLEAR MEDICINE AND BIOLOGY

IF3

2011-02-0136

PREAI

Synthesis and assessment of 99mTc chelate-conjugated bevacizumab for development of specific radiopharmaceutical

NUCLEAR MEDICINE AND BIOLOGY

IF3

2010-08-011

PREAI